← FDA Drug Approvals (Drugs@FDA)
DROSPIRENONE AND ETHINYL ESTRADIOL
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: APOTEX · Approved 2016-09-21
Drug application
- FDA Application #
ANDA205876- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- DROSPIRENONE AND ETHINYL ESTRADIOL
- Generic name
- Drospirenone
- Active ingredients
- DROSPIRENONE; ETHINYL ESTRADIOL
- Dosage form
- TABLET
- Route
- ORAL-28
- Marketing status
- Discontinued
- Sponsor
- APOTEX
- First approval
- 2016-09-21
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown